Introduction
Hypogonadism is caused by failure of the reproductive hormone system to produce adequate sex hormones, most often because the testes or ovaries do not function normally, or because the brain does not send the hormonal signals needed to stimulate them. In practical terms, the condition develops through disruptions in the hypothalamic-pituitary-gonadal axis, the coordinated system that controls sex hormone production and fertility. The main causes fall into several broad categories: direct gonadal damage, signaling defects in the brain or pituitary gland, genetic abnormalities, systemic illness, medication effects, infections, environmental exposures, and age-related decline.
Biological Mechanisms Behind the Condition
Normal sex hormone production depends on a chain of hormonal communication. The hypothalamus releases gonadotropin-releasing hormone, which tells the pituitary gland to produce luteinizing hormone and follicle-stimulating hormone. These pituitary hormones then act on the gonads, where they stimulate production of testosterone in males and estrogen and progesterone in females, as well as sperm and egg development. When this system works properly, hormone levels are regulated by feedback loops that keep production within a narrow range.
Hypogonadism develops when one or more parts of this system are disrupted. In primary hypogonadism, the gonads themselves are unable to respond normally. The pituitary may still release normal or elevated levels of luteinizing hormone and follicle-stimulating hormone, but the testes or ovaries cannot generate enough sex hormones. In secondary hypogonadism, the problem begins higher in the system, in the hypothalamus or pituitary. The gonads may be structurally intact, but they do not receive sufficient stimulation. This distinction matters because the biological mechanism is different even though the end result, low sex hormone production, is similar.
At the cellular level, hypogonadism can arise from loss of hormone-producing cells, damage to hormone receptors, suppression of signaling pathways, impaired blood supply, or inflammatory injury. Chronic illness can also alter the brain’s release of reproductive hormones through stress pathways, nutritional deficits, and changes in energy balance. In many cases, the condition reflects a combination of impaired hormone synthesis and altered feedback signaling rather than a single isolated defect.
Primary Causes of Hypogonadism
Gonadal failure is one of the major direct causes. In males, the testes may lose the ability to produce testosterone or sperm because of congenital defects, injury, radiation, chemotherapy, autoimmune damage, or age-related degeneration of Leydig and germ cells. In females, the ovaries may fail to produce adequate estrogen and release eggs because of follicular depletion, premature ovarian insufficiency, surgical removal, or tissue damage. Once the hormone-producing tissue is impaired, the body can no longer maintain normal reproductive hormone levels.
Genetic conditions are another major cause. Certain inherited disorders interfere with development of the gonads or the hormonal control centers of the brain. For example, chromosomal abnormalities can disrupt the formation or function of the testes or ovaries. Other genetic defects affect hormone receptors, enzyme pathways, or migration of specialized neurons that control reproductive signaling. These defects can produce hypogonadism from birth or emerge later when development fails to progress normally.
Damage to the hypothalamus or pituitary gland can also lead to hypogonadism. Tumors, surgery, radiation, trauma, and infiltrative diseases may impair production of gonadotropin-releasing hormone, luteinizing hormone, or follicle-stimulating hormone. Without those signals, the gonads receive insufficient stimulation. Because the gonads themselves may be intact, this form often reflects a communication failure rather than a primary gland failure. Pituitary disease is especially important because the gland also controls other endocrine systems, so hypogonadism may appear alongside thyroid, adrenal, or growth hormone abnormalities.
Age-related decline contributes to hypogonadism in many people. In men, testosterone production gradually decreases with aging due to reduced testicular responsiveness, altered hypothalamic signaling, and increased comorbidity burden. In women, menopause represents a more abrupt form of gonadal failure caused by depletion of ovarian follicles. In both sexes, advancing age changes hormone feedback, tissue responsiveness, and the reserve capacity of the reproductive axis.
Contributing Risk Factors
Genetic influences can raise susceptibility even when hypogonadism is not immediately obvious at birth. Variants in genes involved in gonadal development, hormone synthesis, or hypothalamic-pituitary signaling may reduce reproductive reserve. Some individuals inherit partial defects that do not fully block hormone production but make the system more vulnerable to later stress or illness. In these cases, the genetic contribution is often a predisposition rather than a complete cause.
Environmental exposures can interfere with endocrine function. Certain chemicals are capable of acting as endocrine disruptors, altering hormone signaling by mimicking, blocking, or changing the metabolism of sex hormones. Heavy metals, industrial solvents, pesticides, and some plastic-associated compounds have been associated with reproductive hormone disturbance. The biological effect can involve direct toxic injury to gonadal tissue, altered steroid synthesis, or interference with the hypothalamic-pituitary feedback loop.
Infections may contribute when they affect the gonads or the central hormonal control system. Viral orchitis, for example, can injure testicular tissue and impair testosterone production. Some infections can trigger inflammation of the pituitary or hypothalamus, disrupting hormonal signaling. Severe systemic infections can also suppress reproductive hormones temporarily through stress-mediated changes in brain signaling and inflammatory cytokines.
Hormonal changes outside the reproductive axis may also matter. Disorders of the thyroid, adrenal glands, prolactin secretion, or insulin regulation can influence gonadal function indirectly. Excess prolactin suppresses gonadotropin-releasing hormone, while thyroid disease can alter the metabolism and availability of sex hormones. Chronic elevations in stress hormones may inhibit reproductive signaling, particularly when the body interprets prolonged illness or energy deficit as a state in which reproduction should be downregulated.
Lifestyle factors can contribute biologically, especially when they affect energy balance and overall metabolic health. Severe undernutrition, excessive exercise, obesity, alcohol misuse, smoking, and some forms of substance use can all alter the hypothalamic-pituitary-gonadal axis. Low energy availability can reduce pulsatile gonadotropin-releasing hormone release, while obesity can change hormone metabolism and increase aromatization of testosterone to estrogen in some tissues. Alcohol and drugs may damage gonadal tissue or interfere with pituitary signaling.
How Multiple Factors May Interact
Hypogonadism often develops through overlapping mechanisms rather than a single isolated cause. A person with a genetic predisposition may remain hormonally normal until a second factor, such as chemotherapy, severe illness, or chronic malnutrition, reduces the margin of function in the reproductive axis. Likewise, aging can make the gonads less resilient to environmental toxins, infections, or inflammatory disease. The result is a cumulative effect in which each factor weakens part of the system until hormone production falls below the level needed for normal function.
The endocrine system is interconnected, so disruption in one organ can influence several others. For example, pituitary dysfunction may lower reproductive hormones directly and also affect thyroid or adrenal function, which in turn can further suppress reproductive signaling. Chronic inflammation can alter metabolic hormones, stress hormones, and immune signaling at the same time. Because these systems regulate one another through feedback loops, the presence of multiple disturbances can amplify the hormonal deficit more than any single cause would alone.
Variations in Causes Between Individuals
The cause of hypogonadism differs from person to person because reproductive hormone regulation is shaped by genetics, developmental history, age, and overall health. A child with a chromosomal abnormality may develop hypogonadism because the reproductive organs never mature normally. A middle-aged adult may develop it after pituitary injury or chronic systemic disease. An older adult may experience it because the gonads have gradually lost functional reserve. The same diagnosis can therefore reflect very different physiological pathways.
Environmental exposure also helps explain variation. People with similar symptoms may have different histories of toxin exposure, medication use, infection, nutrition, or alcohol intake. Some have a primary gonadal problem, while others have a central signaling defect. In many patients, the condition is not the result of one dramatic event but of how several risk factors accumulate over time. This is why the biological cause may be obvious in one individual and subtle or multifactorial in another.
Conditions or Disorders That Can Lead to Hypogonadism
Several medical conditions can directly or indirectly produce hypogonadism. Klinefelter syndrome and Turner syndrome are classic chromosomal disorders that impair gonadal development and lead to primary hormone deficiency. In these conditions, the reproductive tissue does not form or function normally, so hormone production remains insufficient despite pituitary stimulation.
Autoimmune diseases can also contribute. In autoimmune gonadal failure, the immune system attacks hormone-producing tissue, gradually reducing its capacity. Autoimmune disorders may also involve the pituitary or hypothalamus, which can interrupt central hormonal signaling. Because immune-mediated injury can be chronic and progressive, hormone loss may unfold over time rather than appearing suddenly.
Hemochromatosis, a disorder of excess iron accumulation, can injure both the pituitary gland and the gonads. Iron deposition damages hormone-producing cells and can disrupt the signaling pathway at multiple levels. Similarly, chronic kidney disease, liver disease, and diabetes can alter sex hormone metabolism, suppress central reproductive signaling, or reduce tissue responsiveness to hormones. These conditions do not always damage the gonads directly, but they create an internal environment that is unfavorable for normal reproductive function.
Obesity is another important associated condition. Excess adipose tissue changes the metabolism of sex steroids, increases inflammatory signaling, and can suppress the hormonal pulses needed to stimulate the gonads. In males, this may contribute to lower testosterone levels; in females, it can disrupt ovulation and produce a pattern of hormonal imbalance. The effect is mediated through both metabolic and endocrine pathways.
Brain and pituitary disorders such as tumors, congenital pituitary deficiencies, head trauma, and infiltrative diseases can reduce gonadotropin production. Because these organs coordinate multiple endocrine functions, even a localized lesion can have broad effects. The resulting hypogonadism is often secondary, reflecting inadequate instruction from the central regulatory system rather than failure of the gonads themselves.
Conclusion
Hypogonadism develops when the body cannot produce or regulate sex hormones adequately. The most important causes are primary gonadal failure, defects in hypothalamic or pituitary signaling, genetic disorders, age-related decline, and damage from illness, infection, medication, or environmental exposure. Many cases arise through more than one pathway, with one factor weakening the reproductive axis and another pushing it past the threshold for normal hormone production.
Understanding the biological mechanisms behind hypogonadism makes the condition easier to explain. It is not simply a matter of low hormones; it is a failure in one or more steps of a tightly regulated endocrine system. By tracing where the disruption occurs, whether in the gonads, the brain, or the broader metabolic environment, it becomes clear why different people develop hypogonadism for different reasons and why the condition can arise from both inherited and acquired causes.